December 09, 2025

AACI Issues Statement on Death of Dr. Ed Chu

The Association of American Cancer Institutes (AACI) offered a statement on the death of Dr. Ed Chu. Portions of that statement are provided here.

The ASCO Post

December 05, 2025

Zanzalintinib Plus Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer

The phase III STELLAR-303 trial evaluated the anti-VEGFR–related multitargeted tyrosine kinase inhibitor zanzalintinib in combination with the PD-L1 inhibitor atezolizumab vs the multikinase inhibitor...

The ASCO Post

November 25, 2025

Dual Immunotherapy Extended Progression-Free Survival in Metastatic Colorectal Cancer Subgroup

An immunotherapy combination for advanced, highly mutated colorectal cancer has significantly delayed disease progression vs single-agent therapy, according to data presented at the 2025 ASCO Gastroin...

The ASCO Post

November 18, 2025

Study Finds Personalized Risk Messages Had No Effect in Raising Colorectal Cancer Screening Participation

A randomized controlled trial to determine the rate of colorectal screening uptake after informing patients due for screening and their providers about the patient’s risk for advanced colorectal neopl...

The ASCO Post

January 01, 0001

Assessment of Pathologic Response in Patients With Locally Advanced Rectal Cancer: Implications of the Park et al. Study

A landmark study reveals the critical role of neoadjuvant chemoradiotherapy in locally advanced rectal cancer treatment, underscoring the importance of treatment response evaluation for better patient outcomes.

JADPRO

January 02, 2025

FDA Approves Nivolumab and Hyaluronidase-nvhy for Subcutaneous Injection

On December 27, 2024, the U.S. Food and Drug Administration approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) for subcutaneous injection across approved adult, solid tumor nivolumab indicatio...

The ASCO Post

August 02, 2023

Gastrointestinal Symptoms May Be Prevalent in Geriatric Female Colorectal Cancer Survivors

About 80% of geriatric female colorectal cancer survivors may experience a range of gastrointestinal symptoms years after receiving a diagnosis and treatment for their tumors, according to a recent st...

The ASCO Post

December 04, 2023

Consuming Navy Beans May Improve Gut Health, Regulate Immune and Inflammatory Processes in Colorectal Cancer Survivors

Researchers investigated whether the regular consumption of navy beans could help improve the gut microbiome of colorectal cancer survivors.

The ASCO Post

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post